15-23646784-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_019066.5(MAGEL2):c.959C>T(p.Ala320Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000391 in 1,535,036 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 8/12 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_019066.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEL2 | NM_019066.5 | c.959C>T | p.Ala320Val | missense_variant | 1/1 | ENST00000650528.1 | NP_061939.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEL2 | ENST00000650528.1 | c.959C>T | p.Ala320Val | missense_variant | 1/1 | NM_019066.5 | ENSP00000497810.1 |
Frequencies
GnomAD3 genomes AF: 0.00000660 AC: 1AN: 151440Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000728 AC: 1AN: 137390Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 74416
GnomAD4 exome AF: 0.00000361 AC: 5AN: 1383596Hom.: 0 Cov.: 32 AF XY: 0.00000439 AC XY: 3AN XY: 682732
GnomAD4 genome AF: 0.00000660 AC: 1AN: 151440Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74004
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 13, 2022 | The c.959C>T (p.A320V) alteration is located in exon 1 (coding exon 1) of the MAGEL2 gene. This alteration results from a C to T substitution at nucleotide position 959, causing the alanine (A) at amino acid position 320 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Nov 08, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with MAGEL2-related conditions. This variant is present in population databases (no rsID available, gnomAD 0.002%). This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 320 of the MAGEL2 protein (p.Ala320Val). - |
Schaaf-Yang syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 04, 2020 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at